{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:55:37Z","timestamp":1774612537650,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23753-6","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:31:09Z","timestamp":1753169469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of cytomegalovirus in severely ill patients with intractable COVID-19; a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yea-Yuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Chen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane Wen-Wei","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"1","key":"23753_CR1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1186\/s12879-021-06698-0","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liu X, Sang L, et al. Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study. BMC Infect Dis. 2021;21(1):1026.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 1","key":"23753_CR2","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1093\/infdis\/jiz638","volume":"221","author":"H Imlay","year":"2020","unstructured":"Imlay H, Limaye AP. Current understanding of cytomegalovirus reactivation in critical illness. J Infect Dis. 2020;221(Suppl 1):S94-102.","journal-title":"J Infect Dis"},{"issue":"5","key":"23753_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/v15051165","volume":"15","author":"G Schinas","year":"2023","unstructured":"Schinas G, Moustaka V, Polyzou E, Almyroudi MP. Targeting CMV reactivation to optimize care for critically ill COVID-19 patients: a review on the therapeutic potential of antiviral treatment. Viruses. 2023;15(5):1165.","journal-title":"Viruses"},{"issue":"5","key":"23753_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.12669\/pjms.39.5.7301","volume":"39","author":"R Gozukucuk","year":"2023","unstructured":"Gozukucuk R, Kilic HH. The relationship between CMV reactivation, anti-cytokine treatment and mortality in critical COVID-19 patients. Pak J Med Sci. 2023;39(5):1286\u201390.","journal-title":"Pak J Med Sci"},{"issue":"3","key":"23753_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/jmv.27421","volume":"94","author":"Y Yamamoto","year":"2022","unstructured":"Yamamoto Y, Shiroyama T, Hirata H, et al. Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19. J Med Virol. 2022;94(3):1067\u201373.","journal-title":"J Med Virol"},{"issue":"5","key":"23753_CR6","doi-asserted-by":"publisher","first-page":"e0303995","DOI":"10.1371\/journal.pone.0303995","volume":"19","author":"T Tassaneeyasin","year":"2024","unstructured":"Tassaneeyasin T, Sungkanuparph S, Srichatrapimuk S, et al. Prevalence and risk factors of cytomegalovirus reactivation in critically ill patients with COVID-19 pneumonia. PLoS One. 2024;19(5):e0303995.","journal-title":"PLoS One"},{"issue":"10","key":"23753_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/17512433.2021.1949286","volume":"14","author":"G Kenny","year":"2021","unstructured":"Kenny G, Mallon PWG. Tocilizumab for the treatment of non-critical COVID-19 pneumonia: an overview of the rationale and clinical evidence to date. Expert Rev Clin Pharmacol. 2021;14(10):1279\u201387.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"23753_CR8","first-page":"163","volume":"38","author":"J Febbo","year":"2024","unstructured":"Febbo J, Revels J, Ketai L. Viral pneumonias. Radiol Clin North Am. 2024;38(1):163\u201382.","journal-title":"Radiol Clin North Am"},{"key":"23753_CR9","unstructured":"Taiwan Centers for Disease Control (CDC). Guidelines for clinical management of SARS-CoV-2 infection version 26. Sep. 01 2024. https:\/\/www.cdc.gov.tw\/File\/Get\/s4WoxgkALsvVxp6xuBamJA. Accessed 06 Sept 2024."},{"issue":"1","key":"23753_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12979-021-00218-z","volume":"18","author":"C S\u00f6derberg-Naucl\u00e9r","year":"2021","unstructured":"S\u00f6derberg-Naucl\u00e9r C. Does reactivation of cytomegalovirus contribute to severe COVID-19 disease? Immun Ageing. 2021;18(1):12.","journal-title":"Immun Ageing"},{"issue":"7","key":"23753_CR11","doi-asserted-by":"publisher","first-page":"ofac286","DOI":"10.1093\/ofid\/ofac286","volume":"9","author":"S Schoninger","year":"2022","unstructured":"Schoninger S, Dubrovskaya Y, Marsh K, et al. Outcomes of cytomegalovirus viremia treatment in critically ill patients with COVID-19 infection. Open Forum Infect Dis. 2022;9(7):ofac286.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"23753_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00134-022-06716-y","volume":"48","author":"I Gatto","year":"2022","unstructured":"Gatto I, Biagioni E, Coloretti I, et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. Intensive Care Med. 2022;48(6):706\u201313.","journal-title":"Intensive Care Med"},{"key":"23753_CR13","doi-asserted-by":"publisher","first-page":"e01402","DOI":"10.1016\/j.idcr.2022.e01402","volume":"27","author":"M Kim","year":"2022","unstructured":"Kim M, Jacob J, Mayer D, Eckardt PA. Cytomegalovirus reactivation in critically-ill coronavirus disease 2019 patients: a case series of 11 patients. IDCases. 2022;27:e01402.","journal-title":"IDCases"},{"issue":"3","key":"23753_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","volume":"51","author":"A Simonnet","year":"2021","unstructured":"Simonnet A, Engelmann I, Moreau AS, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infectious Diseases Now. 2021;51(3):296\u20139.","journal-title":"Infectious Diseases Now"},{"issue":"4","key":"23753_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/187152611796504773","volume":"11","author":"DF Florescu","year":"2011","unstructured":"Florescu DF, Kalil AC. Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit. Infectious Disorders. 2011;11(4):354\u201364.","journal-title":"Infectious Disorders"},{"issue":"6 Pt 1","key":"23753_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jmii.2022.08.007","volume":"55","author":"RC Huang","year":"2022","unstructured":"Huang RC, Chiu CH, Shang HS, et al. Clinical characteristics analysis of COVID-19 patients from the first significant community outbreak by SARS-CoV-2 variant B.1.1.7 in Taiwan as experienced from a single Northern medical center. J Microbiol Immunol Infect. 2022;55(6 Pt 1):1036\u201343.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"23753_CR17","doi-asserted-by":"publisher","first-page":"e0268530","DOI":"10.1371\/journal.pone.0268530","volume":"17","author":"S Weber","year":"2022","unstructured":"Weber S, Kehl V, Erber J, et al. CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS One. 2022;17(5):e0268530.","journal-title":"PLoS One"},{"issue":"1","key":"23753_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.37201\/req\/068.2022","volume":"36","author":"MJ P\u00e9rez-Granda","year":"2023","unstructured":"P\u00e9rez-Granda MJ, Catal\u00e1n P, Mu\u00f1oz P, et al. Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: a point prevalence study in a general hospital. Rev Esp Quimioter. 2023;36(1):45\u201351.","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"23753_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13054-020-03252-3","volume":"24","author":"P Le Balc\u2019h","year":"2020","unstructured":"Le Balc\u2019h P, Pinceaux K, Pronier C, Seguin P, Tadi\u00e9 JM, Reizine F. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care. 2020;24(1):530.","journal-title":"Crit Care"},{"issue":"5","key":"23753_CR20","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1080\/13685538.2020.1774748","volume":"23","author":"M Parohan","year":"2020","unstructured":"Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416\u201324.","journal-title":"Aging Male"},{"issue":"1","key":"23753_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12879-021-06300-7","volume":"21","author":"J Gao","year":"2021","unstructured":"Gao J, Zhong L, Wu M, et al. Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study. BMC Infect Dis. 2021;21(1):602.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"23753_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/infdis\/jiac020","volume":"226","author":"C Alanio","year":"2022","unstructured":"Alanio C, Verma A, Mathew D, et al. Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization. J Infect Dis. 2022;226(3):463\u201373.","journal-title":"J Infect Dis"},{"issue":"5","key":"23753_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2144","volume":"30","author":"S Kadambari","year":"2020","unstructured":"Kadambari S, Klenerman P, Pollard AJ. Why the elderly appear to be more severely affected by COVID-19: the potential role of immunosenescence and CMV. Rev Med Virol. 2020;30(5): e2144.","journal-title":"Rev Med Virol"},{"issue":"9","key":"23753_CR24","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/08850666211053990","volume":"37","author":"JH Naendrup","year":"2022","unstructured":"Naendrup JH, Garcia Borrega J. Reactivation of EBV and CMV in severe COVID-19-epiphenomena or trigger of hyperinflammation in need of treatment? A large case series of critically ill patients. J Intensive Care Med. 2022;37(9):1152\u201358.","journal-title":"J Intensive Care Med"},{"issue":"4","key":"23753_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1440-1754.2007.01215.x","volume":"44","author":"MH Chen","year":"2008","unstructured":"Chen MH, Chen PC, Jeng SF, et al. High perinatal seroprevalence of cytomegalovirus in Northern Taiwan. J Paediatr Child Health. 2008;44(4):166\u20139.","journal-title":"J Paediatr Child Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23753-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:32:04Z","timestamp":1757266324000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23753-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23753"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23753-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Taipei City Hospital\u2019s Ethics Committee approved this study (IRB No. TCHIRB-11008016-E). All patient data were anonymized and disconnected, with no minors included in the study. The IRB waived the requirement for written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2522"}}